{"nct_id":"NCT02316106","title":"A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma","status":"COMPLETED","status_verified_date":"2025-04","start_date":"2015-05-20","start_date_type":"ACTUAL","primary_completion_date":"2023-06-02","primary_completion_date_type":"ACTUAL","completion_date":"2024-06-03","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}